MEDICINOVA, INC. Additional Paid in Capital, Common Stock
MEDICINOVA, INC. (MNOV) had Additional Paid in Capital, Common Stock of $481.00 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-13
- 2026-06-30: Additional Paid in Capital, Common Stock $481.00M.
- 2026-03-31: Additional Paid in Capital, Common Stock $480.82M.
- 2025-12-31: Additional Paid in Capital, Common Stock $480.41M.
- 2025-09-30: Additional Paid in Capital, Common Stock $479.99M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $481.00M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $480.82M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $480.41M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $479.99M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $479.83M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $479.63M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $479.34M 10-K · filed 2026-03-10 |
| 2024-09-30 | $479.08M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $478.57M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $478.36M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $478.15M 10-K · filed 2025-02-19 |
| 2023-09-30 | $478.39M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $478.17M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $477.84M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $477.44M 10-K · filed 2024-02-15 |
| 2022-09-30 | $477.31M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $477.15M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $476.87M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $476.79M 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $477.51M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $476.68M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $475.53M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $454.30M 10-K · filed 2022-02-16 |
| 2020-09-30 | $453.54M 10-Q · filed 2020-10-26 |
| 2020-06-30 | $447.38M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $445.03M 10-Q · filed 2020-04-23 |
| 2019-12-31 | $444.02M 10-K · filed 2021-02-19 |
| 2019-09-30 | $441.49M 10-Q · filed 2019-10-24 |
| 2019-06-30 | $437.94M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $435.92M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $429.29M 10-K · filed 2020-02-13 |
| 2018-09-30 | $429.53M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $424.78M 10-Q · filed 2018-07-23 |
| 2018-03-31 | $421.62M 10-Q · filed 2018-04-25 |
| 2017-12-31 | $380.16M 10-K · filed 2019-02-13 |
| 2017-09-30 | $374.63M 10-Q · filed 2017-10-23 |
| 2017-06-30 | $369.54M 10-Q · filed 2017-07-26 |
| 2017-03-31 | $366.12M 10-Q · filed 2017-04-26 |
| 2016-12-31 | $364.89M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |